Literature DB >> 20084544

Maternal hormones during early pregnancy: a cross-sectional study.

Tianhui Chen1, Eva Lundin, Kjell Grankvist, Anne Zeleniuch-Jacquotte, Marianne Wulff, Yelena Afanasyeva, Helena Schock, Robert Johansson, Per Lenner, Goran Hallmans, Goran Wadell, Paolo Toniolo, Annekatrin Lukanova.   

Abstract

BACKGROUND: Little is known about correlates of first-trimester pregnancy hormones as in most studies maternal hormones have been measured later in gestation. We examined the associations of maternal characteristics and child sex with first-trimester maternal concentrations of four hormones implicated in breast cancer: human chorionic gonadotropin (hCG), alpha-fetoprotein (AFP), insulin-like growth factor (IGF)-I, and IGF-II.
METHODS: About 338 serum samples donated to the Northern Sweden Maternity Cohort (NSMC), 1975-2001, during the first trimester of uncomplicated pregnancies, were analyzed for the hormones of interest as a part of a case-control study. The associations of maternal characteristics and child sex with hormone concentrations were investigated by correlation, general linear regression, and multivariate regression models.
RESULTS: In the first trimester, greater maternal age was inversely correlated with IGF-I and IGF-II. In comparison with women carrying their first child, already parous women had higher IGF-I but lower hCG. Greater maternal weight and smoking were inversely correlated with hCG. No differences in hormone levels by child sex were observed.
CONCLUSIONS: Our analyses indicated that potentially modifiable maternal characteristics (maternal weight and smoking) influence first-trimester pregnancy maternal hormone concentrations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20084544      PMCID: PMC2880501          DOI: 10.1007/s10552-009-9500-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  63 in total

Review 1.  Serum levels of insulin-like growth factor I and its binding proteins in health and disease.

Authors:  Anders Juul
Journal:  Growth Horm IGF Res       Date:  2003-08       Impact factor: 2.372

2.  Longitudinal changes of insulin-like growth factors and their binding proteins throughout normal pregnancy.

Authors:  John M Monaghan; Ian M Godber; Nigel Lawson; Malveen Kaur; Gwen Wark; Derrick Teale; David J Hosking
Journal:  Ann Clin Biochem       Date:  2004-05       Impact factor: 2.057

Review 3.  Antenatal screening for Down's syndrome.

Authors:  N J Wald; A Kennard; A Hackshaw; A McGuire
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

4.  Maternal serum AFP levels in the first trimester of pregnancy.

Authors:  F Olajide; M J Kitau; T Chard
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1989-02       Impact factor: 2.435

5.  Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.

Authors:  B E Richardson; J D Peck; J K Wormuth
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-12       Impact factor: 4.254

6.  Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.

Authors:  J Russo; G Wilgus; I H Russo
Journal:  Am J Pathol       Date:  1979-09       Impact factor: 4.307

7.  Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term.

Authors:  Lars J Vatten; Stein Tore Nilsen; Rønnaug A Odegård; Pål R Romundstad; Rigmor Austgulen
Journal:  Pediatrics       Date:  2002-06       Impact factor: 7.124

8.  Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.

Authors:  Katherine DeLellis; Sabina Rinaldi; Rudolph J Kaaks; Laurence N Kolonel; Brian Henderson; Loic Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-09       Impact factor: 4.254

9.  Prenatal screening for Down syndrome: the problem of recurrent false-positives.

Authors:  Nicholas J Wald; Wayne J Huttly; Alicja R Rudnicka
Journal:  Prenat Diagn       Date:  2004-05       Impact factor: 3.050

10.  Maternal, prenatal and perinatal characteristics and first trimester maternal serum hormone concentrations.

Authors:  R Troisi; R N Hoover; R Thadhani; C-C Hsieh; P Sluss; R Ballard-Barbash; N Potischman
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

View more
  8 in total

1.  Evidence for sexually dimorphic associations between maternal characteristics and anogenital distance, a marker of reproductive development.

Authors:  Emily S Barrett; Lauren E Parlett; J Bruce Redmon; Shanna H Swan
Journal:  Am J Epidemiol       Date:  2013-10-11       Impact factor: 4.897

2.  Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort.

Authors:  Renée T Fortner; Helena Schock; Rudolf Kaaks; Matti Lehtinen; Eero Pukkala; Hans-Åke Lakso; Minna Tanner; Raija Kallio; Heikki Joensuu; Jaana Korpela; Adetunji T Toriola; Göran Hallmans; Kjell Grankvist; Anne Zeleniuch-Jacquotte; Paolo Toniolo; Eva Lundin; Heljä-Marja Surcel
Journal:  Cancer Res       Date:  2016-10-26       Impact factor: 12.701

3.  Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer.

Authors:  Tianhui Chen; Helja-Marja Surcel; Eva Lundin; Marjo Kaasila; Hans-Ake Lakso; Helena Schock; Rudolf Kaaks; Pentti Koskela; Kjell Grankvist; Goran Hallmans; Eero Pukkala; Anne Zeleniuch-Jacquotte; Paolo Toniolo; Matti Lehtinen; Annekatrin Lukanova
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-21       Impact factor: 4.254

Review 4.  Pregnancy-induced changes in breast cancer risk.

Authors:  Irma H Russo; Jose Russo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09       Impact factor: 2.673

5.  Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer.

Authors:  Paolo Toniolo; Kjell Grankvist; Marianne Wulff; Tianhui Chen; Robert Johansson; Helena Schock; Per Lenner; Göran Hallmans; Matti Lehtinen; Rudolf Kaaks; Göran Wadell; Anne Zeleniuch-Jacquotte; Eva Lundin; Annekatrin Lukanova
Journal:  Cancer Res       Date:  2010-08-16       Impact factor: 12.701

6.  Predictors of Steroid Hormone Concentrations in Early Pregnancy: Results from a Multi-Center Cohort.

Authors:  Emily S Barrett; Omar Mbowe; Sally W Thurston; Samantha Butts; Christina Wang; Ruby Nguyen; Nicole Bush; J Bruce Redmon; Sukrita Sheshu; Shanna H Swan; Sheela Sathyanarayana
Journal:  Matern Child Health J       Date:  2019-03

7.  Chlamydia trachomatis and Anti-MUC1 Serology and Subsequent Risk of High-Grade Serous Ovarian Cancer: A Population-Based Case-Control Study in Northern Sweden.

Authors:  Sarah Jonsson; Eva Lundin; Fredrik Elgh; Ulrika Ottander; Annika Idahl
Journal:  Transl Oncol       Date:  2019-12-02       Impact factor: 4.243

8.  Gestational age-specific normative values and determinants of serum progesterone through the first trimester of pregnancy.

Authors:  Chee Wai Ku; Xiaoxuan Zhang; Valencia Ru-Yan Zhang; John Carson Allen; Nguan Soon Tan; Truls Østbye; Thiam Chye Tan
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.